Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
- 1 October 2000
- journal article
- case report
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 16 (5) , 377-380
- https://doi.org/10.1097/00006565-200010000-00022
Abstract
Ecstasy (MDMA) is an amphetamine derivative of growing popularity. The drug produces a range of toxicities when taken either in standard doses or overdose. In overdose it has major toxicity, producing several different life-threatening manifestations. Hepatotoxicity and hyponatremia are common but poorly understood consequences of MDMA overdose. The drug can produce long-term, if not permanent, neurologic sequelae by destruction of serotonergic neurons. Chronic Ecstasy use can result in psychosis, depression, and suicidal ideation. In the ED setting, it is essential for physicians to recognize and treat appropriately those who present with intoxication from this drug.Keywords
This publication has 28 references indexed in Scilit:
- Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal RecoveryJournal of Neuroscience, 1999
- MDMA (Ecstasy) and the Rave: A ReviewPediatrics, 1997
- Two Very Different Fatal Cases Associated with the Use of Methylenedioxyethylamphet-amine (MDEA): Eve as Deadly as AdamJournal of Toxicology: Clinical Toxicology, 1996
- “Designer drugs” — A current perspectiveThe Journal of Emergency Medicine, 1990
- Legal Limbo for EcstasyScience, 1988
- ‘Designer Drugs’Medical Toxicology, 1988
- A growing industry and menace: makeshift laboratory's designer drugsJAMA, 1986
- Controls Over the Manufacture of MDMAJournal of Psychoactive Drugs, 1986
- Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: EntactogensJournal of Psychoactive Drugs, 1986
- The Background and Chemistry of MDMAJournal of Psychoactive Drugs, 1986